Opioid addiction does not respond to willpower alone, and the research on that point is unambiguous. Yet a lot of people still approach it that way, trying to quit cold turkey or white-knuckling through withdrawal without any medical support, then feeling like a failure when it does not hold. Medication-assisted treatment for opioid addiction exists precisely because the condition has a physiological component that determination alone cannot address. If you or someone you care about is trying to understand what this treatment actually involves, this is a clear and honest place to start.
Understanding What Medication-Assisted Treatment Actually Is
Medication-assisted treatment, commonly referred to as MAT, combines FDA-approved medications with behavioral therapies and counseling to treat opioid use disorder. The goal is not simply to manage withdrawal and move on. MAT supports the brain and body in stabilizing over time while the work of recovery continues in parallel through therapy, group support, and ongoing clinical care.
This approach carries strong endorsement from the Substance Abuse and Mental Health Services Administration (SAMHSA), the American Society of Addiction Medicine, and numerous other clinical bodies. Research consistently shows that MAT reduces illicit opioid use, decreases overdose mortality, improves treatment retention, and supports long-term recovery in ways that non-medication approaches alone often cannot match.
It is also worth addressing a common misconception directly: MAT is not substituting one addiction for another. The medications used in MAT work on opioid receptors in the brain, but they do so in a clinically controlled, medically supervised way. This is a legitimate medical treatment for a medical condition, and the stigma surrounding it does real harm to people who could benefit from it.
The Medications Most Commonly Used in MAT
Several FDA-approved medications are used in outpatient MAT for opioid use disorder, and the right one depends on the individual’s clinical situation, medical history, and the nature of their dependence.
Buprenorphine is one of the most widely used and commonly prescribed medications in combination with naloxone under brand names such as Suboxone. Buprenorphine reduces cravings and withdrawal symptoms without producing the intense euphoric effect associated with full opioid agonists, making it well-suited for outpatient settings where someone can take their medication at home under a clinical provider’s supervision. According to the Centers for Disease Control and Prevention, buprenorphine treatment significantly reduces the risk of opioid overdose.
Methadone is another option, dispensed through federally regulated opioid treatment programs that require daily clinic visits, particularly in the early stages of treatment. It is an effective choice for individuals with longer or more complex histories of opioid dependence.
Naltrexone, available in an extended-release injectable form under the brand name Vivitrol, works differently. It blocks opioid receptors entirely and prevents opioids from producing any euphoric effect, making it appropriate for individuals who have already cleared opioids from their system and want a non-opioid-based approach to managing relapse prevention. Because it precipitates withdrawal if opioids are still present in the body, the timing of initiation requires careful clinical guidance.
Your prescribing provider will walk you through these options in detail during your evaluation and make a recommendation based on your full clinical picture. The right medication is not one-size-fits-all, and a thorough assessment is always the starting point.
How Counseling and Therapy Fit Into the MAT Model
Medication is the medical foundation of MAT, but it is not the complete picture. Outpatient addiction treatment that relies on medication alone misses much of what drives sustained recovery. Counseling addresses the behavioral, emotional, and social factors that contribute to opioid use disorder, including trauma, co-occurring mental health conditions, patterns of thinking, relationship dynamics, and the circumstances that developed alongside the addiction.
Individual counseling provides a one-on-one space to work through these factors directly with a trained clinician. Our outpatient substance use counseling supports people at each stage of their recovery, helping them develop coping skills, recognize and respond to triggers, and build a foundation that makes progress sustainable over time.
Group counseling for substance use is another component that many people in recovery find essential. Sharing experiences with others who are navigating similar challenges reduces the isolation that often accompanies addiction, builds accountability, and creates a sense of community that many individuals do not have elsewhere in their lives. The combination of medication, individual counseling, and group support is what makes MAT a genuinely comprehensive approach rather than a shortcut.
Psychiatric Support for Co-Occurring Mental Health Conditions
A significant portion of people with opioid use disorder also live with co-occurring mental health conditions such as depression, anxiety, PTSD, or trauma-related disorders. This combination is sometimes called a dual diagnosis, and addressing both conditions simultaneously produces better outcomes than treating either one in isolation.
Our outpatient psychiatric services for substance use are specifically designed to address this. Licensed psychiatrists and licensed nurse practitioners in psychiatry evaluate and treat co-occurring mental health conditions alongside substance use treatment, creating a more complete and clinically coherent plan. When someone is managing both opioid use disorder and a mental health condition, integrated care is not a luxury; it is a clinical necessity.
Who Is a Good Candidate for Outpatient MAT?
Adults with a diagnosis of opioid use disorder who are medically stable and do not require a higher level of care are typically appropriate candidates for outpatient MAT. This distinction is worth making clearly.
Our outpatient addiction treatment does not include medical detox, inpatient treatment, residential care, or partial hospitalization. All of our services are outpatient only. When someone’s clinical situation requires a higher level of care, our team provides referrals to appropriate resources, because getting the right level of care matters more than keeping someone at a level that does not fit their needs.
For many people, outpatient MAT is precisely the right level, especially when work obligations, family responsibilities, or personal circumstances make inpatient or residential care impractical. Outpatient care also allows people to apply the skills and insights they gain in treatment directly to their everyday lives, in real time and in context.
Telehealth has also significantly expanded access to MAT. For individuals who face transportation barriers, live at a distance from a clinic, or find remote appointments more manageable, our telehealth services offer a flexible and effective way to connect with a medication management provider and counselor without traveling to a physical office.
What the Research Says About MAT Outcomes
The evidence supporting MAT for opioid use disorder is not incremental. SAMHSA reports that MAT reduces opioid use, reduces criminal activity associated with drug use, and significantly improves patients’ ability to gain and maintain employment. It also reduces the transmission of infectious diseases like HIV and hepatitis C that are associated with injection drug use.
Retention in treatment is one of the strongest predictors of positive long-term recovery outcomes, and MAT consistently improves retention compared to non-medication approaches. None of this means MAT is appropriate for every person in every circumstance, but someone who has struggled to sustain recovery through other approaches deserves to know that this option exists, that it is evidence-based, and that stigma is not a reason to avoid exploring it.
Conclusion
Medication-assisted treatment for opioid addiction is a well-researched, clinically supported approach that helps people stabilize physically, engage more fully in counseling, and build toward sustained recovery. It works best as part of a comprehensive outpatient treatment plan that combines medication, individual therapy, group support, and psychiatric care where needed. If you or someone you love is navigating opioid use disorder, reaching out to a qualified provider is the most important next step you can take.
Bleuler Psychotherapy Center
Bleuler Psychotherapy Center offers outpatient addiction treatment at our Forest Hills location, including medication-assisted treatment for opioid addiction combined with individual counseling, group counseling, and psychiatric services for co-occurring conditions. MAT services are also available via telehealth for eligible individuals. We are licensed by the New York State Office of Addiction Services and Supports (OASAS) and the New York State Office of Mental Health (OMH), and our team includes credentialed alcoholism and substance use counselors, licensed psychiatrists, and licensed nurse practitioners in psychiatry.
We accept many insurance plans, including Medicaid, Medicare, Blue Cross Blue Shield (BCBS), Aetna, Cigna, and others. Coverage varies by plan, and sliding scale fees are available for those who qualify. Contact our Forest Hills office to schedule an evaluation and learn more about our outpatient addiction treatment services.
Please note: Substance use and addiction services are available at our Forest Hills location and via telehealth. These services are not offered at the Jackson Heights location.
Frequently Asked Questions
Is medication-assisted treatment for opioid addiction available without a prior detox?
This depends on the medication. Buprenorphine can generally be initiated in an outpatient setting without a prior detox, though providers follow specific clinical guidelines for the induction process. Naltrexone requires that opioids have cleared the system before initiation. Your prescribing provider will walk you through the appropriate process based on your clinical evaluation.
Does insurance cover MAT in New York?
Many insurance plans, including Medicaid and Medicare, cover outpatient medication-assisted treatment. Coverage varies by plan, so confirming the specifics of your coverage before starting treatment is always a recommended step.
How long does medication-assisted treatment typically last?
The duration of MAT varies widely by individual. Some people remain on MAT medications for months, others for years. Clinical guidelines from SAMHSA and the American Society of Addiction Medicine do not specify a fixed duration because longer treatment retention is generally associated with better recovery outcomes.
Can I receive MAT via telehealth in New York?
Yes. Following regulatory updates in recent years, buprenorphine can be prescribed via telehealth without an in-person visit in many circumstances. Eligibility and specifics can vary, so contacting a provider directly is the best way to confirm what applies to your situation.
What is the difference between buprenorphine and methadone in MAT?
Both medications address opioid cravings and withdrawal symptoms, but they work differently and are delivered through different structures. Buprenorphine is typically prescribed in outpatient settings and taken at home. Methadone for opioid use disorder is dispensed through federally regulated opioid treatment programs and requires daily clinic visits, especially early in treatment. A prescribing provider can help determine which is clinically appropriate based on your history and current situation.
Bleuler Psychotherapy Center is a nonprofit behavioral health organization dedicated to providing compassionate, affordable, and accessible mental health care for children, adolescents, adults, couples, and families in Queens, New York. With more than 75 years of service, Bleuler offers psychotherapy, psychiatry, substance use treatment, telehealth, and specialized support tailored to the diverse needs of their community. Their mission focuses on empowering individuals through evidence-based, collaborative care that promotes healing, growth, and overall well-being.
